Ignite Creation Date:
2025-12-24 @ 12:45 PM
Ignite Modification Date:
2025-12-27 @ 4:07 PM
Study NCT ID:
NCT02510261
Status:
COMPLETED
Last Update Posted:
2023-12-06
First Post:
2015-07-16
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Participants Who Have Already Been Treated With ALN-TTR02 (Patisiran)
Sponsor:
Alnylam Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Amyloidosis | View |